Risk of cancer in inflflammatory bowel disease treated with azathioprine: A UK population-based case-control study - Commentary

Tom Huizinga^*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Number of pages	1
Journal	International Journal of Advances in Rheumatology
Volume	8
Issue number	4
State	Published - Dec 1 2010

ASJC Scopus subject areas

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{3b206f8391ca48feb70161aa35fbc29d,

title = "Risk of cancer in inflflammatory bowel disease treated with azathioprine: A UK population-based case-control study - Commentary",

author = "Tom Huizinga and Peter Nigrovic and Eric Ruderman and Hendrik Schulze-Koops",

year = "2010",

month = dec,

day = "1",

language = "English (US)",

volume = "8",

journal = "International Journal of Advances in Rheumatology",

issn = "1478-856X",

publisher = "Remedica Medical Education and Publishing Ltd",

number = "4",

}

TY - JOUR

T1 - Risk of cancer in inflflammatory bowel disease treated with azathioprine

T2 - A UK population-based case-control study - Commentary

AU - Huizinga, Tom

AU - Nigrovic, Peter

AU - Ruderman, Eric

AU - Schulze-Koops, Hendrik

PY - 2010/12/1

Y1 - 2010/12/1

UR - http://www.scopus.com/inward/record.url?scp=84863881690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863881690&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:84863881690

SN - 1478-856X

VL - 8

JO - International Journal of Advances in Rheumatology

JF - International Journal of Advances in Rheumatology

IS - 4

ER -